Inoue Kazuhide
Department of Molecular and System Pharmacology, Graduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi ku, Fukuoka 812 8582, Japan.
Brain Nerve. 2007 Jul;59(7):739-46.
Neuropathic pain is often a consequence of nerve injury through surgery, bone compression, diabetes or infection. This type of pain can be so severe that even light touching can be intensely painful. Unfortunately, this state is generally resistant to currently available treatments. There is abundant evidence that activated microglia are a key player for causing the pain and ATP receptors expressed in microglia have an important role to activate microglia. In this review, we summarize the role of microglia and ATP receptors in neuropathic pain signalling. The activated microglia express P2X4 after nerve injury, which can be stimulated by endogenous ATP, resulting in the release of BDNF which is one of key molecules involving in neuropathic pain. The microglia also express many molecules that were reported to be connected in the pain. Understanding the key roles of these ATP receptors in microglia may lead to new strategies for the management of intractable chronic pain.
神经性疼痛通常是由手术、骨压迫、糖尿病或感染等导致的神经损伤引起的。这种疼痛可能非常严重,以至于即使是轻微触碰也会剧痛难忍。不幸的是,目前的治疗方法通常对这种情况无效。有大量证据表明,活化的小胶质细胞是导致疼痛的关键因素,小胶质细胞中表达的ATP受体在激活小胶质细胞方面起着重要作用。在本综述中,我们总结了小胶质细胞和ATP受体在神经性疼痛信号传导中的作用。神经损伤后,活化的小胶质细胞表达P2X4,内源性ATP可刺激该受体,导致脑源性神经营养因子(BDNF)释放,BDNF是神经性疼痛相关的关键分子之一。小胶质细胞还表达许多据报道与疼痛相关的分子。了解这些ATP受体在小胶质细胞中的关键作用可能会为顽固性慢性疼痛的治疗带来新策略。